Toledano Miranda Jayne insider trades
Toledano Miranda Jayne has filed 22 Form 4s with the SEC that we hold, for Entera Bio Ltd. (ENTX) (Chief Executive Officer, Director), Journey Medical Corp (DERM) (Director) and Nexgel, INC. (NXGL) (Director). Across all of them we count 6 purchases worth $122.7K and 0 sales worth $0 reported on Form 4. In the last 12 months: 1 purchase ($19.9K) and 0 sales ($0). The largest single trade was a purchase of 30,000 shares of Entera Bio Ltd. worth $30.3K, dated 2023-04-04. The first filing on our record is dated 2022-01-03 and the latest 2026-08-07.
Entera Bio Ltd. (ENTX)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-01-14 | P, purchase reported on Form 4 | 6,800 | $19.0K | 2022-01-19 |
| 2022-11-11 | P, purchase reported on Form 4 | 50,000 | $26.5K | 2022-11-14 |
| 2023-04-04 | P, purchase reported on Form 4 | 30,000 | $30.3K | 2023-04-06 |
| 2023-12-22 | P, purchase reported on Form 4 | 23,952 | $17.0K | 2023-12-27 |
| 2025-12-29 | P, purchase reported on Form 4 | 11,000 | $19.9K | 2025-12-30 |
Journey Medical Corp (DERM)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Nexgel, INC. (NXGL)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-12-27 | P, purchase reported on Form 4 | 1,819 | $10.0K | 2022-01-03 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1686530) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms